Publications:

Combating acquired resistance to MAPK inhibitors in melanoma by targeting Abl1/2-mediated reactivation of MEK/ERK/MYC signaling.

Nature Communications

Tripathi, Rakshamani R; Liu, Zulong Z; Jain, Aditi A; Lyon, Anastasia A; Meeks, Christina C; Richards, Dana D; Liu, Jinpeng J; He, Daheng D; Wang, Chi C; Nespi, Marika M; Rymar, Andrey A; Wang, Peng P; Wilson, Melissa M; Plattner, Rina R

Publication Date: 2020-10-29

Variant appearance in text: USH2A: 9999T>G; D3333E

PubMed Link: 33122628

Variant Present in the following documents:

• 41467_2020_19075_MOESM10_ESM.xlsx, sheet 1

View BVdb publication page